12


/ Press Releases
2022.01
TWi officially launches an Authorized Generic of Dexilant® (Dexlansoprazole) Delayed-Release Capsules from Takeda
2021-10
TWi’ ANDA for Metformin HCl Extended-Release Tablets (equivalent to Fortamet®) has been officially approved by US FDA
2021-09
TWi’ ANDA for Testosterone Topical Solution (equivalent to Axiron®) has been officially approved by US FDA
2021-01
TWi officially launches generic Dimethyl Fumarate DR Capsules in TWi label
2020-10
TWi’ ANDA for Dimethyl Fumarate DR Capsules (equivalent to Tecfidera®) has been officially approved by US FDA